Concentrated Broccoli Sprout Extract May Help Fight T2DM

This article originally appeared here.
Share this content:
Concentrated Broccoli Sprout Extract May Help Fight T2DM
Concentrated Broccoli Sprout Extract May Help Fight T2DM

THURSDAY, June 15, 2017 (HealthDay News) -- Sulforaphane, found in cruciferous vegetables such as broccoli, may help obese type 2 diabetes patients better regulate dysglycemia, according to a study published in the June 14 issue of Science Translational Medicine.

Anders Rosengren, M.D., Ph.D., of the University of Gothenburg in Sweden, and colleagues decided to test sulforaphane after screening over 3,800 compounds for their potential to counter certain gene-activity patterns that are associated with type 2 diabetes. Sulforaphane emerged as the most promising candidate.

First, the chemical was tested in the lab, where it partly blocked liver cells from producing glucose. In diabetic lab rats, it seemed to shift certain gene activity in the liver away from a diseased state, the researchers said. The team then recruited 97 patients with type 2 diabetes. Half of the group was randomly assigned to take sulforaphane powder once a day for 12 weeks, in addition to their usual medication. The other half received a placebo powder.

The supplement appeared to be effective only for specific patients -- namely, those who were obese and had poorly controlled blood glucose to start. For this group, average hemoglobin A1c level decreased from 7.38 to 7.04 percent.

Two authors are inventors on patent applications submitted by Lund University that cover the use of sulforaphane to treat exaggerated hepatic glucose production.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths